Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 660

1.

Oral investigational drugs currently in phase I or phase II for the amelioration of menopausal symptoms.

Genazzani AR, Gaspard U, Foidart JM.

Expert Opin Investig Drugs. 2019 Mar;28(3):235-247. doi: 10.1080/13543784.2019.1572114. Epub 2019 Feb 1. Review.

PMID:
30677323
2.

Development of injectable liposomes and drug-in-cyclodextrin-in-liposome formulations encapsulating estetrol to prevent cerebral ischemia of premature babies.

Palazzo C, Laloy J, Delvigne AS, Nys G, Fillet M, Dogne JM, Pequeux C, Foidart JM, Evrard B, Piel G.

Eur J Pharm Sci. 2019 Jan 15;127:52-59. doi: 10.1016/j.ejps.2018.10.006. Epub 2018 Oct 9. No abstract available.

PMID:
30308312
3.

Predominant Role of Nuclear Versus Membrane Estrogen Receptor α in Arterial Protection: Implications for Estrogen Receptor α Modulation in Cardiovascular Prevention/Safety.

Guivarc'h E, Buscato M, Guihot AL, Favre J, Vessières E, Grimaud L, Wakim J, Melhem NJ, Zahreddine R, Adlanmerini M, Loufrani L, Knauf C, Katzenellenbogen JA, Katzenellenbogen BS, Foidart JM, Gourdy P, Lenfant F, Arnal JF, Henrion D, Fontaine C.

J Am Heart Assoc. 2018 Jun 29;7(13). pii: e008950. doi: 10.1161/JAHA.118.008950.

4.

Effect of estetrol, a selective nuclear estrogen receptor modulator, in mouse models of arterial and venous thrombosis.

Valéra MC, Noirrit-Esclassan E, Dupuis M, Fontaine C, Lenfant F, Briaux A, Cabou C, Garcia C, Lairez O, Foidart JM, Payrastre B, Arnal JF.

Mol Cell Endocrinol. 2018 Dec 5;477:132-139. doi: 10.1016/j.mce.2018.06.010. Epub 2018 Jun 19.

PMID:
29928930
5.

Heterogeneity of estrogen receptor α and progesterone receptor distribution in lesions of deep infiltrating endometriosis of untreated women or during exposure to various hormonal treatments.

Brichant G, Nervo P, Albert A, Munaut C, Foidart JM, Nisolle M.

Gynecol Endocrinol. 2018 Aug;34(8):651-655. doi: 10.1080/09513590.2018.1433160. Epub 2018 Jan 31.

PMID:
29383962
6.

Estetrol, a Fetal Selective Estrogen Receptor Modulator, Acts on the Vagina of Mice through Nuclear Estrogen Receptor α Activation.

Benoit T, Valera MC, Fontaine C, Buscato M, Lenfant F, Raymond-Letron I, Tremollieres F, Soulie M, Foidart JM, Game X, Arnal JF.

Am J Pathol. 2017 Nov;187(11):2499-2507. doi: 10.1016/j.ajpath.2017.07.013. Epub 2017 Aug 19.

PMID:
28827141
7.

Estetrol combined with drospirenone: an oral contraceptive with high acceptability, user satisfaction, well-being and favourable body weight control.

Apter D, Zimmerman Y, Beekman L, Mawet M, Maillard C, Foidart JM, Coelingh Bennink HJT.

Eur J Contracept Reprod Health Care. 2017 Aug;22(4):260-267. doi: 10.1080/13625187.2017.1336532. Epub 2017 Jun 22.

PMID:
28641030
8.

Pharmacokinetics of the fetal estrogen estetrol in a multiple-rising-dose study in postmenopausal women.

Coelingh Bennink HJT, Verhoeven C, Zimmerman Y, Visser M, Foidart JM, Gemzell-Danielsson K.

Climacteric. 2017 Jun;20(3):285-289. doi: 10.1080/13697137.2017.1291608. Epub 2017 Mar 7.

PMID:
28267365
9.

Pharmacodynamic effects of the fetal estrogen estetrol in postmenopausal women: results from a multiple-rising-dose study.

Coelingh Bennink HJT, Verhoeven C, Zimmerman Y, Visser M, Foidart JM, Gemzell-Danielsson K.

Menopause. 2017 Jun;24(6):677-685. doi: 10.1097/GME.0000000000000823.

PMID:
28169916
10.

Improved computer-assisted analysis of the global lymphatic network in human cervical tissues.

Balsat C, Signolle N, Goffin F, Delbecque K, Plancoulaine B, Sauthier P, Samouëlian V, Béliard A, Munaut C, Foidart JM, Blacher S, Noël A, Kridelka F.

Mod Pathol. 2017 Feb;30(2):313. doi: 10.1038/modpathol.2016.196. No abstract available.

11.

Estrogen receptors and estetrol-dependent neuroprotective actions: a pilot study.

Tskitishvili E, Pequeux C, Munaut C, Viellevoye R, Nisolle M, Noël A, Foidart JM.

J Endocrinol. 2017 Jan;232(1):85-95. Epub 2016 Oct 31.

12.

Response to the editorial 'Menopausal health: the potential for fetal-placental estrogen use'.

Coelingh Bennink HJ, Verhoeven C, Zimmerman Y, Visser M, Foidart JM, Gemzell-Danielsson K.

Maturitas. 2016 Dec;94:181. doi: 10.1016/j.maturitas.2016.08.018. Epub 2016 Aug 24. No abstract available.

PMID:
27616547
13.

Reduced hemostatic effects with drospirenone-based oral contraceptives containing estetrol vs. ethinyl estradiol.

Kluft C, Zimmerman Y, Mawet M, Klipping C, Duijkers IJ, Neuteboom J, Foidart JM, Bennink HC.

Contraception. 2017 Feb;95(2):140-147. doi: 10.1016/j.contraception.2016.08.018. Epub 2016 Sep 1.

PMID:
27593335
14.

Clinical effects of the fetal estrogen estetrol in a multiple-rising-dose study in postmenopausal women.

Coelingh Bennink HJ, Verhoeven C, Zimmerman Y, Visser M, Foidart JM, Gemzell-Danielsson K.

Maturitas. 2016 Sep;91:93-100. doi: 10.1016/j.maturitas.2016.06.017. Epub 2016 Jun 23.

15.

Use of estetrol with other steroids for attenuation of neonatal hypoxic-ischemic brain injury: to combine or not to combine?

Tskitishvili E, Pequeux C, Munaut C, Viellevoye R, Nisolle M, Noël A, Foidart JM.

Oncotarget. 2016 Jun 7;7(23):33722-43. doi: 10.18632/oncotarget.9591.

16.

Bleeding pattern and cycle control with estetrol-containing combined oral contraceptives: results from a phase II, randomised, dose-finding study (FIESTA).

Apter D, Zimmerman Y, Beekman L, Mawet M, Maillard C, Foidart JM, Coelingh Bennink HJ.

Contraception. 2016 Oct;94(4):366-73. doi: 10.1016/j.contraception.2016.04.015. Epub 2016 May 3.

17.

Quantitative Assessment of Mouse Mammary Gland Morphology Using Automated Digital Image Processing and TEB Detection.

Blacher S, Gérard C, Gallez A, Foidart JM, Noël A, Péqueux C.

Endocrinology. 2016 Apr;157(4):1709-16. doi: 10.1210/en.2015-1601. Epub 2016 Feb 24.

PMID:
26910307
18.

Supplementation of transport and freezing media with anti-apoptotic drugs improves ovarian cortex survival.

Henry L, Fransolet M, Labied S, Blacher S, Masereel MC, Foidart JM, Noel A, Nisolle M, Munaut C.

J Ovarian Res. 2016 Feb 12;9:4. doi: 10.1186/s13048-016-0216-0.

19.

Elastin density: Link between histological and biomechanical properties of vaginal tissue in women with pelvic organ prolapse?

de Landsheere L, Brieu M, Blacher S, Munaut C, Nusgens B, Rubod C, Noel A, Foidart JM, Nisolle M, Cosson M.

Int Urogynecol J. 2016 Apr;27(4):629-35. doi: 10.1007/s00192-015-2901-8. Epub 2015 Dec 10.

PMID:
26658755
20.

Inhibition of ovulation by administration of estetrol in combination with drospirenone or levonorgestrel: Results of a phase II dose-finding pilot study.

Duijkers IJ, Klipping C, Zimmerman Y, Appels N, Jost M, Maillard C, Mawet M, Foidart JM, Coelingh Bennink HJ.

Eur J Contracept Reprod Health Care. 2015;20(6):476-89. doi: 10.3109/13625187.2015.1074675.

21.

The Activation Function-1 of Estrogen Receptor Alpha Prevents Arterial Neointima Development Through a Direct Effect on Smooth Muscle Cells.

Smirnova NF, Fontaine C, Buscato M, Lupieri A, Vinel A, Valera MC, Guillaume M, Malet N, Foidart JM, Raymond-Letron I, Lenfant F, Gourdy P, Katzenellenbogen BS, Katzenellenbogen JA, Laffargue M, Arnal JF.

Circ Res. 2015 Oct 9;117(9):770-8. doi: 10.1161/CIRCRESAHA.115.306416. Epub 2015 Aug 27.

22.

Mesenchymal Stem Cells Shed Amphiregulin at the Surface of Lung Carcinoma Cells in a Juxtacrine Manner.

Carnet O, Lecomte J, Masset A, Primac I, Durré T, Maertens L, Detry B, Blacher S, Gilles C, Péqueux C, Paupert J, Foidart JM, Jerusalem G, Cataldo D, Noel A.

Neoplasia. 2015 Jul;17(7):552-63. doi: 10.1016/j.neo.2015.07.002.

23.

The Cancer Cell Oxygen Sensor PHD2 Promotes Metastasis via Activation of Cancer-Associated Fibroblasts.

Kuchnio A, Moens S, Bruning U, Kuchnio K, Cruys B, Thienpont B, Broux M, Ungureanu AA, Leite de Oliveira R, Bruyère F, Cuervo H, Manderveld A, Carton A, Hernandez-Fernaud JR, Zanivan S, Bartic C, Foidart JM, Noel A, Vinckier S, Lambrechts D, Dewerchin M, Mazzone M, Carmeliet P.

Cell Rep. 2015 Aug 11;12(6):992-1005. doi: 10.1016/j.celrep.2015.07.010. Epub 2015 Jul 30.

24.

Unique effects on hepatic function, lipid metabolism, bone and growth endocrine parameters of estetrol in combined oral contraceptives.

Mawet M, Maillard C, Klipping C, Zimmerman Y, Foidart JM, Coelingh Bennink HJ.

Eur J Contracept Reprod Health Care. 2015;20(6):463-75. doi: 10.3109/13625187.2015.1068934. Epub 2015 Jul 27.

25.

Combined estrogenic and anti-estrogenic properties of estetrol on breast cancer may provide a safe therapeutic window for the treatment of menopausal symptoms.

Gérard C, Mestdagt M, Tskitishvili E, Communal L, Gompel A, Silva E, Arnal JF, Lenfant F, Noel A, Foidart JM, Péqueux C.

Oncotarget. 2015 Jul 10;6(19):17621-36.

26.

Isoform 165 of vascular endothelial growth factor in collagen matrix improves ovine cryopreserved ovarian tissue revascularisation after xenotransplantation in mice.

Henry L, Labied S, Fransolet M, Kirschvink N, Blacher S, Noel A, Foidart JM, Nisolle M, Munaut C.

Reprod Biol Endocrinol. 2015 Mar 7;13:12. doi: 10.1186/s12958-015-0015-2.

27.

Soluble factors regulated by epithelial-mesenchymal transition mediate tumour angiogenesis and myeloid cell recruitment.

Suarez-Carmona M, Bourcy M, Lesage J, Leroi N, Syne L, Blacher S, Hubert P, Erpicum C, Foidart JM, Delvenne P, Birembaut P, Noël A, Polette M, Gilles C.

J Pathol. 2015 Aug;236(4):491-504. doi: 10.1002/path.4546. Epub 2015 May 12.

28.

Influence of mouse strain on ovarian tissue recovery after engraftment with angiogenic factor.

Fransolet M, Henry L, Labied S, Masereel MC, Blacher S, Noël A, Foidart JM, Nisolle M, Munaut C.

J Ovarian Res. 2015 Mar 27;8:14. doi: 10.1186/s13048-015-0142-6.

29.

A membrane-type-1 matrix metalloproteinase (MT1-MMP)-discoidin domain receptor 1 axis regulates collagen-induced apoptosis in breast cancer cells.

Assent D, Bourgot I, Hennuy B, Geurts P, Noël A, Foidart JM, Maquoi E.

PLoS One. 2015 Mar 16;10(3):e0116006. doi: 10.1371/journal.pone.0116006. eCollection 2015.

30.

Restoring testosterone levels by adding dehydroepiandrosterone to a drospirenone containing combined oral contraceptive: I. Endocrine effects.

Zimmerman Y, Foidart JM, Pintiaux A, Minon JM, Fauser BC, Cobey K, Coelingh Bennink HJ.

Contraception. 2015 Feb;91(2):127-33. doi: 10.1016/j.contraception.2014.11.002. Epub 2014 Nov 13.

PMID:
25604900
31.

Restoring testosterone levels by adding dehydroepiandrosterone to a drospirenone containing combined oral contraceptive: II. Clinical effects.

Zimmerman Y, Foidart JM, Pintiaux A, Minon JM, Fauser BC, Cobey K, Coelingh Bennink HJ.

Contraception. 2015 Feb;91(2):134-42. doi: 10.1016/j.contraception.2014.11.008. Epub 2014 Nov 15.

PMID:
25496917
32.

Estetrol is a weak estrogen antagonizing estradiol-dependent mammary gland proliferation.

Gérard C, Blacher S, Communal L, Courtin A, Tskitishvili E, Mestdagt M, Munaut C, Noel A, Gompel A, Péqueux C, Foidart JM.

J Endocrinol. 2015 Jan;224(1):85-95. doi: 10.1530/JOE-14-0549. Epub 2014 Oct 30.

PMID:
25359896
33.

EGFR activation and signaling in cancer cells are enhanced by the membrane-bound metalloprotease MT4-MMP.

Paye A, Truong A, Yip C, Cimino J, Blacher S, Munaut C, Cataldo D, Foidart JM, Maquoi E, Collignon J, Delvenne P, Jerusalem G, Noel A, Sounni NE.

Cancer Res. 2014 Dec 1;74(23):6758-70. doi: 10.1158/0008-5472.CAN-13-2994. Epub 2014 Oct 15.

34.

ISGE statement on oral emergency contraception.

Glasier A, Gemzell-Danielsson K, Bouchard P, Genazzani AR, Al-Azzawi F, Berga S, Birkhaeuser M, Brincat M, De Melo NR, Foidart JM, Kenemans P, Lunenfeld B, Maruo T, Milewicz A, Naftolin F, Ng EH, Schindler A, Simon C, Simoncini T, Simpson E, Siseles N, Smetnik V, Tarlatzis B, von Schoultz B.

Gynecol Endocrinol. 2014 Oct;30(10):681-2. doi: 10.3109/09513590.2014.950649. Review.

PMID:
25242337
35.

The uterine and vascular actions of estetrol delineate a distinctive profile of estrogen receptor α modulation, uncoupling nuclear and membrane activation.

Abot A, Fontaine C, Buscato M, Solinhac R, Flouriot G, Fabre A, Drougard A, Rajan S, Laine M, Milon A, Muller I, Henrion D, Adlanmerini M, Valéra MC, Gompel A, Gerard C, Péqueux C, Mestdagt M, Raymond-Letron I, Knauf C, Ferriere F, Valet P, Gourdy P, Katzenellenbogen BS, Katzenellenbogen JA, Lenfant F, Greene GL, Foidart JM, Arnal JF.

EMBO Mol Med. 2014 Oct;6(10):1328-46. doi: 10.15252/emmm.201404112.

36.

Altered α-defensin 5 expression in cervical squamocolumnar junction: implication in the formation of a viral/tumour-permissive microenvironment.

Hubert P, Herman L, Roncarati P, Maillard C, Renoux V, Demoulin S, Erpicum C, Foidart JM, Boniver J, Noël A, Delvenne P, Herfs M.

J Pathol. 2014 Dec;234(4):464-77. doi: 10.1002/path.4435. Epub 2014 Oct 6.

PMID:
25196670
37.

Estetrol attenuates neonatal hypoxic-ischemic brain injury.

Tskitishvili E, Nisolle M, Munaut C, Pequeux C, Gerard C, Noel A, Foidart JM.

Exp Neurol. 2014 Nov;261:298-307. doi: 10.1016/j.expneurol.2014.07.015. Epub 2014 Jul 28.

PMID:
25079370
38.

Changes in elastin density in different locations of the vaginal wall in women with pelvic organ prolapse.

de Landsheere L, Blacher S, Munaut C, Nusgens B, Rubod C, Noel A, Foidart JM, Cosson M, Nisolle M.

Int Urogynecol J. 2014 Dec;25(12):1673-81. doi: 10.1007/s00192-014-2431-9. Epub 2014 May 28.

PMID:
24866277
39.

Effects of varying antigens and adjuvant systems on the immunogenicity and safety of investigational tetravalent human oncogenic papillomavirus vaccines: results from two randomized trials.

Van Damme P, Leroux-Roels G, Simon P, Foidart JM, Donders G, Hoppenbrouwers K, Levin M, Tibaldi F, Poncelet S, Moris P, Dessy F, Giannini SL, Descamps D, Dubin G.

Vaccine. 2014 Jun 17;32(29):3694-705. doi: 10.1016/j.vaccine.2014.03.040. Epub 2014 Mar 25.

40.

Impact of a new levonorgestrel intrauterine system, Levosert(®), on heavy menstrual bleeding: results of a one-year randomised controlled trial.

Mawet M, Nollevaux F, Nizet D, Wijzen F, Gordenne V, Tasev N, Segedi D, Marinescu B, Enache A, Parhomenko V, Frankenne F, Foidart JM.

Eur J Contracept Reprod Health Care. 2014 Jun;19(3):169-79. doi: 10.3109/13625187.2014.894184. Epub 2014 Mar 26.

41.

Improved computer-assisted analysis of the global lymphatic network in human cervical tissues.

Balsat C, Signolle N, Goffin F, Delbecque K, Plancoulaine B, Sauthier P, Samouëlian V, Béliard A, Munaut C, Foidart JM, Blacher S, Noël A, Kridelka F.

Mod Pathol. 2014 Jun;27(6):887-98. doi: 10.1038/modpathol.2013.195. Epub 2013 Dec 6. Erratum in: Mod Pathol. 2017 Feb;30(2):313.

42.

Laser-induced choroidal neovascularization model to study age-related macular degeneration in mice.

Lambert V, Lecomte J, Hansen S, Blacher S, Gonzalez ML, Struman I, Sounni NE, Rozet E, de Tullio P, Foidart JM, Rakic JM, Noel A.

Nat Protoc. 2013 Nov;8(11):2197-211. doi: 10.1038/nprot.2013.135. Epub 2013 Oct 17.

43.

Expression of the gamma 2 chain of laminin-332 in eutopic and ectopic endometrium of patients with endometriosis.

Locci R, Nisolle M, Angioni S, Foidart JM, Munaut C.

Reprod Biol Endocrinol. 2013 Sep 26;11:94. doi: 10.1186/1477-7827-11-94.

44.

Histology of the vaginal wall in women with pelvic organ prolapse: a literature review.

De Landsheere L, Munaut C, Nusgens B, Maillard C, Rubod C, Nisolle M, Cosson M, Foidart JM.

Int Urogynecol J. 2013 Dec;24(12):2011-20. doi: 10.1007/s00192-013-2111-1. Epub 2013 May 7. Review.

45.

Sunitinib inhibits inflammatory corneal lymphangiogenesis.

Detry B, Blacher S, Erpicum C, Paupert J, Maertens L, Maillard C, Munaut C, Sounni NE, Lambert V, Foidart JM, Rakic JM, Cataldo D, Noël A.

Invest Ophthalmol Vis Sci. 2013 May 3;54(5):3082-93. doi: 10.1167/iovs.12-10856.

46.

Evidence for cross-talk between the LH receptor and LH during implantation in mice.

Gridelet V, Tsampalas M, Berndt S, Hagelstein MT, Charlet-Renard C, Conrath V, Ectors F, Hugé F, Munaut C, Foidart JM, Geenen V, Perrier d'Hauterive S.

Reprod Fertil Dev. 2013;25(3):511-22. doi: 10.1071/RD11241.

47.

Isoform 111 of vascular endothelial growth factor (VEGF111) improves angiogenesis of ovarian tissue xenotransplantation.

Labied S, Delforge Y, Munaut C, Blacher S, Colige A, Delcombel R, Henry L, Fransolet M, Jouan C, Perrier d'Hauterive S, Noël A, Nisolle M, Foidart JM.

Transplantation. 2013 Feb 15;95(3):426-33. doi: 10.1097/TP.0b013e318279965c.

PMID:
23380862
48.

Interplay between KLF4 and ZEB2/SIP1 in the regulation of E-cadherin expression.

Koopmansch B, Berx G, Foidart JM, Gilles C, Winkler R.

Biochem Biophys Res Commun. 2013 Feb 22;431(4):652-7. doi: 10.1016/j.bbrc.2013.01.070. Epub 2013 Jan 29.

49.

[Herpes hepatic failure during the third quarter of pregnancy].

Giner C, Marotta ML, Vaneyck AS, Thiry A, Foidart JM.

Rev Med Liege. 2012 Nov;67(11):557-9. French.

50.

Hyperglycosylated human chorionic gonadotropin stimulates angiogenesis through TGF-β receptor activation.

Berndt S, Blacher S, Munaut C, Detilleux J, Perrier d'Hauterive S, Huhtaniemi I, Evain-Brion D, Noël A, Fournier T, Foidart JM.

FASEB J. 2013 Apr;27(4):1309-21. doi: 10.1096/fj.12-213686. Epub 2012 Dec 11.

PMID:
23233533

Supplemental Content

Loading ...
Support Center